Chemoinformaics analysis of 4-[2-[2-(4-HYDROXYPHENYL)ETHOXY]ETHYL]PHENOL
| Molecular Weight | 258.317 | nRot | 6 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 7 |
| Exact Molecular Weight | 258.126 | nRing | 2 |
| Solubility: LogS | -1.139 | nHRing | 0 |
| Solubility: LogP | -2.402 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 41.1283 |
| nHD | 2 | BPOL | 19.7937 |
| QED | 0.569 |
| Synth | 3.976 |
| Natural Product Likeliness | 0.718 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.022 |
| HIA | 0.845 |
| CACO-2 | -6.069 |
| MDCK | 0.000433187 |
| BBB | 0.487 |
| PPB | 0.168826 |
| VDSS | 0.346 |
| FU | 0.693979 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.034 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.126 |
| CYP2c9-sub | 0.251 |
| CYP2d6-inh | 0.049 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.045 |
| CL | 4.158 |
| T12 | 0.694 |
| hERG | 0.013 |
| Ames | 0.014 |
| ROA | 0.024 |
| SkinSen | 0.473 |
| Carcinogencity | 0.164 |
| EI | 0.05 |
| Respiratory | 0.113 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.599199 |